Release Date: 19/12/11 11:01 Summary: Bullabulling Scoping Study - 19-12-11 Price Sensitive: Yes Download Document 245.06KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%